MOS vs TRVI · P/E 161, rev $5.82B vs $2.32B cap
The Mosaic Company (MOS) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported MOS revenue for 2026-06-30 was $5.82B. Net income was -$530.4M. Revenue was up 94.2% from 2026-03-31 to 2026-06-30. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
TRVI does not have a complete income-statement cache yet.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the MOS and TRVI stock pages for the full models.
Not investment advice.